Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

2(33.3%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

N/A

1(16.7%)

Phase 1

1(16.7%)

6Total

Phase 2(2)

Phase 3(1)

Phase 4(1)

N/A(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06515730Phase 4Recruiting

Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction

Role: collaborator

NCT05502900Phase 3Recruiting

Adjuvant Melatonin for Uveal Melanoma

Role: collaborator

NCT04896853Phase 1Active Not Recruiting

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Role: collaborator

NCT04842448Phase 2Completed

Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome

Role: collaborator

NCT04327505Phase 2Terminated

Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19

Role: collaborator

NCT05012852Not ApplicableUnknown

Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis

Role: collaborator

All 6 trials loaded